In this article, we will discuss Anlotinib Tolerability (5). So, let’s get started.
However, it also should be noted that patients receiving anlotinib treatment had a high occurrence of triglyceride and cholesterol elevation. Although these effects did not induce noticeable symptoms, the authors suggested that patients taking anlotinib undergo regular monitoring, particularly considering that some of the listed AEs are related to arterial thromboembolic events; such events were significantly more common in patients treated with anti-VEGFR TKIs, however.